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Porphyromonas gulae proteases influence not only bacterial growth, coaggregation, and 
hemagglutination but also the maintenance of human protein       
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学位論文内容の要旨 
Porphyromonas gulae, previously known as the animal biotype of the human periodontal pathogen P. 
gingivalis, is Gram-negative, anaerobic, rod-shaped, asaccharolytic, black- pigmented, non-motile, 
non-spore-forming, and non-motile. P. gulae organisms have been isolated from the gingival sulcus of 
various animal species, including bear, brushtail, possum, dog, cat, coyote, kangaroo, monkey, ovine, 
wallaby, and wolf. Interestingly, it has also detected in human gingival tissues from healthy and 
diseased sites. Although recent studies have reported that P. gulae possesses a wide variety of 
virulence factors, such as including fimbriae, LPS, and proteases, the proteases have yet to be well 
clarified in details. The present study aimed to clarify the characters of the proteases from varieties of 
P. gulae strains available at this time. Based on biochemical and functional characters similar to the 
factors from P. gingivalis, enzyme roles, hemagglutination, and degradation of host proteins were 
clarified in this study. 
P. gulae strains possess trypsin protease-like activity: P. gulae exhibits several virulence 
characteristics similar to those of the human periodontal pathogen P. gingivalis. However, the 
proteolytic enzyme activities of P. gulae strains have not been fully elucidated. All of the examined P. 
gulae strains as well as the P. gingivalis ATCC 33277 strain consistently produced alkaline phosphatase 
and showed trypsin activity, while no other enzyme activities were detected in any of the strains tested.  
Moreover, protease activity was found in both cell extracts and supernatants, with negligible differences 
among the examined strains. Protease inhibitors, including antipain (cysteine protease inhibitor), 
phenylmethylsulfonyl fluoride (PMSF; serine proteinase inhibitor), tosyllysine chloromethyl ketone 
(TLCK; serine endopeptidase specific inhibitor) and leupeptin (serine protease inhibitor as bacterial 
metabolite, a cathepsin B inhibitor, a calpain inhibitor and a trypsin inhibitor), diminished P. gulae 
proteolytic activity up to 50%. 
Hemagglutination activity: P. gulae and P. gingivalis reportedly possess protease-related and 
hemagglutinin genes. However, the hemagglutination ability of P. gulae has yet to be investigated. The 
present findings showed distinct hemagglutination activity in P. gulae ATCC 51700, and found that 
protease inhibitors, such as antipain, PMSF, TLCK, and leupeptin, failed to cause agglutination of 
mouse erythrocytes. These results suggest that P. gulae proteases may contribute to the 
hemagglutination. 
P. gulae growth: Previous reports noted that P. gingivalis growth mediated by gingipains was reported 
to increase in chemically defined medium (CDM). After inoculation in CDM for the present assays, P. 
gulae ATCC 51700 was found to be in clearly in the stationary phase from 144 h. Furthermore, antipain, 
PMSF, TLCK, and leupeptin inhibited the growth of P. gulae ATCC 51700, suggesting that P. gulae 
proteases may be essential for bacterial growth. 
Coaggregation reaction of P. gulae with A. viscosus: Coaggregation of A. viscosus with P. gingivalis 
has been previously reported. P. gulae ATCC 51700 was found to coaggregate with A. viscosus ATCC 
15987, while inhibition of P. gulae proteases using protease inhibitors significantly abrogated that 
activity of the bacterium. These data suggest that coaggregation reactions between P. gulae ATCC 
51700 and A. viscosus ATCC 15987 are regulated via the activity of P. gulae proteases. 
Morphological changes and inhibition of proliferation of human cells by P. gulae: P. gulae ATCC 
51700 caused rounding and detachment of human gingival carcinoma Ca9-22. The nature of 
morphological changes is reportedly linked to the proliferation rate of host cells infected with 
microorganisms. P. gulae ATCC 51700 inhibited proliferation of Ca9-22 cells in both multiplicity of 
infection (MOI) at 500. Pretreatments with antipain, PMSF, TLCK, and leupeptin prevented inhibition of 
Ca9-22 proliferation by P. gulae ATCC 51700, suggesting that P. gulae proteases cause morphological 
changes in Ca9-22 cells, leading to inhibition of their proliferation. 
Degradation of human proteins by P. gulae: Previous studies have reported that focal contact and 
adherence junction components, including E-cadherin, β-catenin, focal adhesion kinase (FAK), and 
paxillin, were associated with epithelial morphology. Following P. gulae ATCC 51700 infection at an 
MOI of 500, E-cadherin, β-catenin, FAK and paxillin also shown to be cleaved at 6 hours. To further 
evaluate the role of P. gulae proteases, P. gulae ATCC 51700 was preincubated with several protease 
inhibitors prior to bacterial infection. Cleavage of focal contact and adherence proteins by P. gulae 
ATCC 51700 was diminished by antipain, PMSF, TLCK, and leupeptin. Furthermore, degradation of 
recombinant human proteins, γ-globulin and fibrinogen, was observed within 6 hours. Antipain, TLCK, 
and leupeptin were prevented the cleavage of γ-globulin and fibrinogen, while PMSF did not.  
Conclusion: P. gulae proteases would be a crucial virulence factors factor for bacterial colonization, 
such as hemagglutination and coaggregation, and bacterial growth, as well as host defense and cell 












Porphyromonas gulae, a Gram-negative black-pigmented anaerobe, has been associated with periodontal disease 
in companion animals and human. Its virulence has been attributed to various factors, including LPS, fimbriae, 
and proteases. However, the characterization and function of P. gulae proteases have yet to be well clarified. In 
the present study, several proteases associated with P. gulae was characterized and clarified the functions of them. 
Based on biochemical and functional characters similar to the factors from Porphyromonas gingivalis, which is 
a periodontopathic bacteria in human and has been well characterized, enzyme roles, hemagglutination, and 
degradation of host proteins were clarified in this study.  
Both alkaline phosphatase and trypsin activity were identified in all examined P. gulae strains, as well as P. 
gingivalis ATCC 33277. Moreover, proteolytic activity was observed for all P. gulae strains in either cell extract 
or culture supernatant samples. Protease inhibitors, including antipain (cysteine protease inhibitor), 
phenylmethylsulfonyl fluoride (PMSF; serine proteinase inhibitor), tosyl lysine chloromethyl ketone (TLCK; 
serine endopeptidase inhibitor), and leupeptin (serine protease inhibitor as bacterial metabolite, a cathepsin B 
inhibitor, a calpain inhibitor, and a trypsin inhibitor), diminished P. gulae proteolytic activity up to 50%. This 
inhibition resulted in the reductions of bacterial cell growth, hemagglutination, and coaggregation with 
Actinomyces viscosus. In addition, P. gulae inhibited gingival epithelial cells proliferation with small-rounded 
cell morphology at high multiplicity of infection (MOI 500) during 24-hour culture. Moreover, P. gulae caused 
decreases of cell adhesion-related proteins such as E-cadherin, β-catenin, FAK and paxillin at 6 hours. These 
inhibitions were relieved by adding the inhibitors mentioned above. Furthermore, recombinant human proteins 
such as -globulin and fibrinogen were degraded within 6 hours, but relieved by adding the inhibitors. 
Together, these results demonstrated the characters and virulence of P. gulae proteases and the suggested the 
pathogenesis of this bacteria to the periodontal disease in either companion animals and human. This would 
contribute to understand the periodontal disease of companion animal but also the periodontal disease as a 
zoonotic disease. 
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